Abstract

Breast cancer stem cells are regulated by cell intrinsic pathways, as well as by elements in the tumor microenvironment. New evidence suggests an important interaction between the IL-8
receptor CXCR1/2 and HER2 are involved in this regulation. Simultaneous targeting of these pathways provides a novel therapeutic approach.